Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Eurofins Scientific SE: Director/PDMR Shareholding


Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the European Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Analytical Bioventures S.C.A (RCS B89265)
23, Va Fleuri, L-1526 Luxembourg

2.

Reason for the notification

a)

Position / status

Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin

b)

Initial notification / amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurofins Scientific S.E.

 

b)

LEI

529900JEHFM47DYY3S57

 

4.

Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Share

Identification code

ISIN: FR0014000MR3

b)

Nature of the transaction

Acquisition of shares

 

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

EUR 59.8339

1067

d)

Aggregated information

 

— Aggregated volume

1067

 

— Price

EUR 63,842.77

e)

Date of the transaction

2025-06-13

f)

Place of the transaction

XPAR

For more information, please visit www.eurofins.com

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical methods.

Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250618962487/en/

Eurofins Scientific SE Aktie

60,34 €
-0,43 %
Leichte Verluste bei Eurofins Scientific SE heute, der Kurs fällt um -0,43 %.
Noch kein Trend erkennbar: Eurofins Scientific SE mit nur einigen Buy- und Sell-Einschätzungen.
Ein positives, wenn auch nicht starkes, Potenzial für Eurofins Scientific SE mit einem Kursziel von 65 € im Vergleich zu 60.34 €.
Like: 0
Teilen
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Rechtlicher Hinweis

Kommentare